Clin Mol Hepatol > Accepted Articles
Letter “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
Qiong Wang1, Zhongqing Qian2, Xiaodi Yang3, Deyan Chen3, Xiaojing Wang4, Fuliang Chen5
1Department of Infection, The First Affiliated Hospital of Bengbu Medical University, Anhui, China, 233000
2Anhui Provincial Key Laboratory of Chronic Disease Immunology, Anhui Provincial Key Laboratory of Infection and Immunology, Bengbu Medical University, Anhui, China, 233030
3Basic Medical College, Bengbu Medical University, Anhui, China, 233030
4Center of Molecular Diagnosis, The First Affiliated Hospital of Bengbu Medical University, Anhui, China, 233000
5Basic Medical College, Bengbu Medical University Joint Research Center for Regional Diseases of IHM, Anhui, China, 233030
Correspondence :  Fuliang Chen ,
Email: cfl3948636@163.com
Received: March 13, 2025   Accepted: March 19, 2025

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 985
TOTAL : 2631984
Close layer